feed,title,long_url,short_url
Benzinga,FDA Fast-Tracks Review Of Sarepta's Groundbreaking Muscular Dystrophy Treatment With $1B Market In Sight,https://benzinga.com/analyst-ratings/analyst-color/24/02/37184388/fda-fast-tracks-review-of-sareptas-groundbreaking-muscular-dystrophy-treatment-with,https://da.gd/YcJh
